These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

127 related items for PubMed ID: 27849192

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Review of a commercially available hybrid closed-loop insulin-delivery system in the treatment of Type 1 diabetes.
    Stone JY, Haviland N, Bailey TS.
    Ther Deliv; 2018 Feb; 9(2):77-87. PubMed ID: 29235423
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Glucose control during Ramadan fasting in a teenager with type 1 diabetes on MiniMed 670G hybrid closed-loop system.
    Petrovski G, Al Khalaf F, Campbell J, Hussain K, Fisher H, Umer F.
    Acta Diabetol; 2020 Jan; 57(1):105-107. PubMed ID: 31473833
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Perioperative Use of a Hybrid Closed Loop System in an Obese Patient With Type 1 Diabetes Undergoing Metabolic Surgery: Insights Into Changes in Insulin Delivery and Sensitivity.
    Rodriguez-Diaz E, Rizo I, Sullivan C, Steenkamp DW.
    J Diabetes Sci Technol; 2018 Nov; 12(6):1239-1240. PubMed ID: 29957042
    [No Abstract] [Full Text] [Related]

  • 8. Fast-acting insulin aspart (Fiasp®) improves glycemic outcomes when used with MiniMedTM 670G hybrid closed-loop system in simulated trials compared to NovoLog®.
    Grosman B, Wu D, Parikh N, Roy A, Voskanyan G, Kurtz N, Sturis J, Cohen O, Ekelund M, Vigersky R.
    Comput Methods Programs Biomed; 2021 Jun; 205():106087. PubMed ID: 33873075
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Appearance of Do-It-Yourself closed-loop systems to manage type 1 diabetes.
    Hng TM, Burren D.
    Intern Med J; 2018 Nov; 48(11):1400-1404. PubMed ID: 30387315
    [Abstract] [Full Text] [Related]

  • 12. Real-World, Patient-Reported and Clinic Data from Individuals with Type 1 Diabetes Using the MiniMed 670G Hybrid Closed-Loop System.
    DuBose SN, Bauza C, Verdejo A, Beck RW, Bergenstal RM, Sherr J, HYCLO Study Group.
    Diabetes Technol Ther; 2021 Dec; 23(12):791-798. PubMed ID: 34524023
    [Abstract] [Full Text] [Related]

  • 13. Challenges for outpatient closed loop studies: how to assess efficacy.
    Beck RW, Calhoun P, Kollman C.
    Diabetes Technol Ther; 2013 Jan; 15(1):1-3. PubMed ID: 23297669
    [No Abstract] [Full Text] [Related]

  • 14. Fully automated closed-loop insulin delivery versus semiautomated hybrid control in pediatric patients with type 1 diabetes using an artificial pancreas.
    Weinzimer SA, Steil GM, Swan KL, Dziura J, Kurtz N, Tamborlane WV.
    Diabetes Care; 2008 May; 31(5):934-9. PubMed ID: 18252903
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Tools of the trade 2012.
    Cooper AA.
    Diabetes Self Manag; 2012 May; 29(6):30, 32-4, 36-8 passim. PubMed ID: 23330471
    [No Abstract] [Full Text] [Related]

  • 18. A real-world study of user characteristics, safety and efficacy of open-source closed-loop systems and Medtronic 670G.
    Jeyaventhan R, Gallen G, Choudhary P, Hussain S.
    Diabetes Obes Metab; 2021 Aug; 23(8):1989-1994. PubMed ID: 33999488
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Closed loop insulin delivery in diabetes.
    Battelino T, Omladič JŠ, Phillip M.
    Best Pract Res Clin Endocrinol Metab; 2015 Jun; 29(3):315-25. PubMed ID: 26051293
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.